We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-1.36%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$533B
AUM Growth
-$9.35B
Cap. Flow
+$8.45B
Cap. Flow %
1.59%
Top 10 Hldgs %
20.32%
Holding
3,548
New
55
Increased
1,868
Reduced
1,338
Closed
74

Top Buys

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$3.16B
2
MRK icon
Merck
MRK
+$2.72B
3
SLB icon
SLB Ltd
SLB
+$1.62B
4
TGT icon
Target
TGT
+$1.6B
5
GIS icon
General Mills
GIS
+$930M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.81B
2
BLK icon
Blackrock
BLK
+$2.57B
3
USB icon
US Bancorp
USB
+$1.84B
4
MTB icon
M&T Bank
MTB
+$808M
5
HBAN icon
Huntington Bancshares
HBAN
+$595M

Sector Composition

Rank Sector Weight
1 Technology 21.45%
2 Financials 11.9%
3 Healthcare 10.6%
4 Consumer Discretionary 9.01%
5 Industrials 8.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCP
3526
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
-1,019,276
Closed -$34.9M
NKLA
3527
DELISTED
Nikola Corporation Common Stock
NKLA
-478,171
Closed -$569K
NARI
3528
DELISTED
Inari Medical, Inc. Common Stock
NARI
-465,962
Closed -$23.8M
ZUO
3529
DELISTED
Zuora, Inc.
ZUO
-1,197,401
Closed -$11.9M
CTV
3530
DELISTED
Innovid Corp.
CTV
-340,931
Closed -$1.05M
ROIC
3531
DELISTED
Retail Opportunity Investments Corp.
ROIC
-2,379,547
Closed -$41.3M
SUM
3532
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-1,747,361
Closed -$88.4M
RVNC
3533
DELISTED
Revance Therapeutics, Inc.
RVNC
-797,299
Closed -$2.42M
CDMO
3534
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-520,598
Closed -$6.43M
BCOV
3535
DELISTED
Brightcove, Inc.
BCOV
-15,530
Closed -$67.6K
BMTX
3536
DELISTED
BM Technologies, Inc.
BMTX
-10,210
Closed -$49.9K
HTLF
3537
DELISTED
Heartland Financial USA, Inc.
HTLF
-1,601,683
Closed -$98.2M
B
3538
DELISTED
Barnes Group Inc.
B
-974,536
Closed -$46.1M
SMAR
3539
DELISTED
Smartsheet Inc.
SMAR
-1,282,883
Closed -$71.9M
USAP
3540
DELISTED
Universal Stainless & Alloy
USAP
-26,567
Closed -$1.17M
GATO
3541
DELISTED
Gatos Silver, Inc.
GATO
-281,746
Closed -$3.94M
PSTX
3542
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
-589,007
Closed -$5.65M
PFIE
3543
DELISTED
Profire Energy, Inc
PFIE
-27,669
Closed -$70.3K
ME
3544
DELISTED
23andMe Holding Co
ME
-13,371
Closed -$43.5K
ZOM
3545
DELISTED
Zomedica Corp.
ZOM
-412,334
Closed -$49.5K
ARCH
3546
DELISTED
Arch Resources, Inc.
ARCH
-198,404
Closed -$28M
IBTX
3547
DELISTED
Independent Bank Group, Inc.
IBTX
-490,073
Closed -$29.7M
GEAR
3548
DELISTED
Revelyst, Inc.
GEAR
-507,869
Closed -$9.77M

Similar funds

Charles Schwab's Q1 2025 Portfolio in Review

As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
  • Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
  • Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
  • Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
  • Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
  • Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
  • Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.

Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.